Which closed-end funds own Neurocrine Biosciences Inc?
5 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $26M. Security type: common equity. Country: United States. CUSIP 64125C109 · ISIN US64125C1099 · ticker NBIX.
Holdings are historical filings (report dates Jun 30, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| BMEZ BlackRock Health Sciences Term Trust | Healthcare | 1.99% | $21.5M | 127,517 sh | $1.1B | NAV unavailable | Jun 30, 2026 |
| HQL abrdn Life Sciences Investors | Healthcare | 0.40% | $2.7M | 16,247 sh | $690M | 3.5% discount | Jun 30, 2026 |
| BME BlackRock Health Sciences Trust | Healthcare | 0.30% | $1.7M | 10,232 sh | $573M | 3.7% discount | Jun 30, 2026 |
| GRX Gabelli Healthcare & WellnessRx Trust | Healthcare | 0.01% | $16.9K | 100 sh | $228M | NAV unavailable | Jun 30, 2026 |
| BRW Saba Capital Income & Opportunities Fund | U.S. Equity | -0.00% | $-12K | -72 sh | $351M | 17.8% discount | Jul 31, 2026 |
5 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: NEUROCRINE BIOSCIENCES INC.
Issuer-level search for “NBIX” → · Compare two funds’ portfolios →